Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
New Scientist on MSN5d
CAR T-cells enable record-breaking 18-year nerve cancer remissionA person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...
Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...
CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...
CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years. “This is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback